ELSI Implications of Prioritizing Biological Therapies in Times of COVID-19.
作者信息
Druedahl Louise C, Lebret Audrey, Minssen Timo
机构信息
Louise C. Druedahl, M.Sc.Pharm., is a Ph.D. candidate at CORS, University of Copenhagen. Audrey Lebret, LL.D., LL.M., MSc.M., is a postdoctoral researcher at CeBIL, University of Copenhagen. Timo Minssen, LL.D., LL.Lic., LL.M., M.I.C.L, Dipl. Jur. is Professor of Law and the Director of CeBIL, University of Copenhagen.
出版信息
J Law Med Ethics. 2020 Sep;48(3):579-582. doi: 10.1177/1073110520958884.
PMID:33021187
Abstract
摘要
Zotero 插件